Aziyo biologics and lemaitre vascular partner for the distribution of aziyo's cardiovascular portfolio

Silver spring, md., april 20, 2023 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo) (“aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced it has entered into a distribution agreement with lemaitre vascular, inc. (nasdaq: lmat) (“lemaitre”), a provider of vascular devices, implants and services. under the agreement terms, aziyo will grant lemaitre exclusive u.s. distribution rights for the products within its cardiovascular segment: proxicor® pc, proxicor® ctr, tyke® and vascure®.
AZYO Ratings Summary
AZYO Quant Ranking